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Abstract  24 
Plasmodium falciparum, the parasite that causes the deadliest form of malaria, has 25 
evolved multiple proteins known as invasion ligands that bind to specific erythrocyte 26 
receptors to facilitate invasion of human erythrocytes. The EBA-175/glycophorin A 27 
(GPA) and Rh5/basigin ligand-receptor interactions, referred to as invasion pathways, 28 
have been the subject of intense study. In this study, we focused on the lesser 29 
characterized sialic acid-containing receptors glycophorin B (GPB) and glycophorin C 30 
(GPC). Through bioinformatic analysis, we identified extensive variation in glycophorin 31 
B transcript (GYPB) levels in individuals from Benin, suggesting selection from malaria 32 
pressure.  To elucidate the importance of the GPB and GPC receptors relative to the well-33 
described EBA-175/GPA invasion pathway, we used an ex vivo erythrocyte culture 34 
system to decrease expression of GPA, GPB or GPC via lentiviral short hairpin RNA 35 
transduction of erythroid progenitor cells, with global surface proteomic profiling.  We 36 
assessed parasite invasion efficiency into knock down cells using a panel of wild type P. 37 
falciparum laboratory strains and invasion ligand knockout lines, as well as P. falciparum 38 
Senegalese clinical isolates and a short-term culture-adapted strain. For this, we 39 
optimized an invasion assay suitable for use with small numbers of erythrocytes. We 40 
found that all laboratory strains and the majority of field strains tested were dependent on 41 
GPB expression level for invasion. Collective data suggest that the GPA and GPB 42 
receptors are of greater importance than the GPC receptor, supporting a hierarchy of 43 
erythrocyte receptor usage in P. falciparum.  44 
 45 
 46 
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Introduction 47 
Malaria is a disease of major global health importance that is caused by parasites 48 
of the genus Plasmodium, of which Plasmodium falciparum is the most virulent (1).  The 49 
asexual erythrocytic stage of the parasite life cycle is responsible for the symptoms 50 
associated with malaria (1). A key step during this stage is parasite invasion of 51 
erythrocytes mediated by interactions between parasite invasion ligands and their cognate 52 
erythrocyte receptors, which define invasion pathways. Across Plasmodium species, 53 
invasion ligands are grouped into two families – the Duffy binding-like or Erythrocyte 54 
binding-like (DBL/EBL) family, and the Reticulocyte binding-like (RBL) family (2–4).  55 
P. falciparum has four EBL ligands – EBA-175, EBL-1 (PEBL), EBA-140 (BAEBL) and 56 
EBA-181 (JESEBL) and five RBL ligands – Rh1, Rh2a, Rh2b, Rh4 and Rh5.  Of these, 57 
the cognate receptors of five invasion ligands are known – glycophorin A, B and C, 58 
which bind EBA-175 (5), EBL-1 (6, 7) and EBA-140  (8, 9) respectively, and 59 
complement receptor 1 (CR1) and basigin (BSG), receptors for Rh4 (10, 11) and Rh5 60 
(12) respectively.  61 
Invasion pathways can be classified according to their dependence on the 62 
presence of sialic acid on receptors; pathways involving the EBL invasion ligands and 63 
Rh1 are reliant on sialic acid (sialic acid-dependent invasion pathways), while those 64 
involving the remaining RBL ligands are not (sialic acid-independent invasion 65 
pathways).  Although P. falciparum has an extensive array of invasion pathways, not all 66 
are utilized at the same time.  The set of dominant invasion pathways used during 67 
invasion is strain-dependent and has led to a broad classification of P. falciparum strains 68 
as sialic acid-dependent or -independent.  However, laboratory-adapted strains have the 69 
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ability to switch invasion pathway usage when specific receptors or determinants of 70 
interaction are absent from the erythrocyte surface (13, 14).  Furthermore, field isolates 71 
commonly utilize different sets of invasion pathways (15–20). The virulence of P. 72 
falciparum has been partly attributed to its extensive set of invasion pathways, which 73 
enable it to efficiently invade diverse host erythrocytes harboring different receptor 74 
polymorphisms.  75 
Most recently, the Rh5/BSG sialic acid-independent invasion pathway has 76 
received the greatest attention owing to the essentiality of the Rh5/BSG invasion pathway 77 
(12, 20). Other studies have also shown that the EBA-175/GPA sialic acid-dependent 78 
invasion pathway plays a significant role in both sialic acid-dependent and sialic acid-79 
independent strains (21–23). Importantly, naturally occurring anti-EBA-175 and anti-Rh5 80 
invasion-inhibitory antibodies have been identified in malaria-exposed individuals (24–81 
27).   82 
Lesser characterized are the EBA-140/GPC sialic acid-dependent invasion 83 
pathway (8, 9, 28, 29), and the sialic acid-dependent parasite invasion ligand EBA-181 84 
for which no receptor has been identified (30–32). The EBL-1/GPB invasion pathway has 85 
also been poorly characterized and there are contradictory reports regarding the 86 
importance of GPB.  One study reported a complete block in invasion of the sialic acid-87 
independent strain, 7G8, into GPB null (S-s-U-) erythrocytes (33), although a prior study 88 
showed little inhibition of this strain (34). A subsequent study showed a 40-87% range in 89 
invasion efficiency into S-s-U- erythrocytes from five donors (35). Donor to donor blood 90 
group differences and differences in receptors may contribute to the variable invasion 91 
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phenotypes of GPB null cells and underscore a potential weakness of comparing non-92 
isogenic mutant and wild type erythrocytes.   93 
 In a search for novel signatures of P. falciparum infection, we performed 94 
computational analysis of a published dataset of transcriptomic profiles from malaria-95 
infected and healthy Beninese children (36), which led to the discovery that there is wide 96 
variation in GYPB transcripts in healthy individuals. This finding provided the impetus 97 
for a detailed study of the use of the GPB receptor in P. falciparum invasion. In this 98 
study, we used an erythrocyte reverse genetics system (37) to specifically knock down 99 
levels of expression of the sialic acid-dependent receptors GPA,  GPB and GPC. We 100 
report that GPB is a key determinant of P. falciparum invasion.  101 
 102 
Materials and Methods 103 
Bioinformatic analyses. A set of 314 host genes with known or potential roles in 104 
parasite invasion was defined by combining erythroblast-specific genes from HaemAtlas 105 
(38) with blood group genes from the International Society of Blood Transfusion 106 
(http://www.isbtweb.org/). Whole-blood raw transcriptomic data from 61 healthy 107 
Beninese children (36) were obtained from the Gene Expression Omnibus (GSE34404). 108 
Two hundred and thirty-eight genes from the erythroblast-specific/blood group set 109 
defined above are expressed in the Benin dataset. This subset was background-corrected 110 
using the detection p-value and quantile normalized using limma (39). The 95
th
 to 5
th
 111 
quantile ratios were calculated to identify the most variable transcripts. 112 
Ex vivo culture of erythrocytes.  3-10x10
5
 bone marrow-derived CD34
+
 hematopoietic 113 
stem cells (HSCs; Lonza) or CD34
+
 cells derived from peripheral blood of GCSF-114 
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stimulated donors (obtained from the HSCI-Boston Children’s Hospital FACS Core) 115 
were cultured in Iscove’s modified Dulbecco’s medium (IMDM, Biochrom) 116 
supplemented with glutamine (Sigma-Aldrich), holo-human transferrin (Scipac), 117 
recombinant human insulin (Sigma-Aldrich), heparin Choay (USBioAnalyzed) and 5% 118 
solvent/detergent virus-inactivated plasma (Octaplas, Octapharma) as described (40) with 119 
the following modifications. On day 6 or 7, cells were transduced with lentivirus 120 
harboring short hairpin RNA (shRNA) against GYPA (Clone ID: TRCN0000116453), 121 
GYPB (Clone ID: TRCN0000084081) or GYPC (Clone ID: TRCN0000083398) or the 122 
empty vector (pLKO).  Lentiviral particles were either prepared as previously described 123 
(37) or obtained from the RNAi Platform (Broad Institute).  Transduction and subsequent 124 
selection on 2 µg/ml puromycin dihydrochloride (Sigma-Aldrich) were performed as 125 
formerly described (41).  From day 12 or 13 to day 18, cells were co-cultured on a 126 
murine MS-5 stromal cell layer at a cell density of 3-6x10
5 
cells/ml as described (42, 43). 127 
On day 18, cells were re-plated on a fresh MS-5 stromal cell layer.  Cells were harvested 128 
on either day 17 or 18 or day 20 and passed through a 5 µm Supor filter (Pall) to remove 129 
residual nucleated cells. Filtered, enucleated cells were stored at 4°C in incomplete RPMI 130 
[RPMI-1640 (Sigma-Aldrich) supplemented with 25 mM HEPES and 50 mg L
-1
 131 
hypoxanthine] until use in subsequent experiments.  132 
Flow cytometry-based measurement of erythrocyte receptor expression.  133 
Erythrocytes were washed three times in PBS-3% BSA blocking buffer, then pelleted in a 134 
96-well plate at 5x10
5
 erythrocytes per well (cultured erythrocytes) or 1x10
6
 (peripheral 135 
erythrocytes) and finally resuspended in 50 µl (cultured erythrocytes) or 100 µl 136 
(peripheral erythrocytes) of PBS-3% BSA or the appropriate antibody solution.  The 137 
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following antibodies were used at the indicated dilutions: phycoerythrin(PE)-conjugated 138 
anti-DARC (1:10, Miltenyi Biotec), anti-CD71-PE (1:10, Miltenyi Biotec), fluorescein 139 
isothiocyanate(FITC)-conjugated anti-GPA (1:50, Clone 2B7, STEMCELL 140 
Technologies), anti-GPC-FITC (1:500, BRIC 10, Santa Cruz), anti-band 3-FITC [1:100, 141 
BRIC 6-FITC, International Blood Group Reference Laboratory (IBGRL)], anti-BSG 142 
[1:1,000, Clone MEM-M6/6, Axxora (Exbio)], anti-CR1 (1:200, Santa Cruz), anti-DAF 143 
(1:3,000, BRIC 216, IBGRL), anti-RhD (1:20, BRAD3-FITC, IBGRL),  and anti-GPA/B 144 
(1:8,000, Clone E3, Sigma-Aldrich). To measure GPB expression, erythrocytes were 145 
treated with 1 mg/ml trypsin (Sigma-Aldrich) to remove GPA before incubation in the 146 
GPA/B antibody. For measurement of GPA and GPC expression in Senegal, the 147 
following probes were used in addition to the aforementioned antibodies: anti-GPA – 148 
BRIC 256 IgG (IBGRL, 1:100,000) and BRIC 256-FITC fab fragment (1:20); anti-GPC – 149 
BRIC 10 IgG (IBGRL, 1:500,000), BRIC 10-FITC fab fragment (1:100) and BRIC 4 IgG 150 
(IBGRL, 1:8,000). Fab fragments were produced from whole IgG by papain digestion 151 
(Pierce Fab Preparation kit; Thermo Scientific) and FITC-labelled (ProtOn Fluorescein 152 
Labelling kit, Vector Laboratories), followed by extensive dialysis in PBS.  153 
 Cells were incubated for 1 h at room temperature and washed three times in 154 
blocking buffer. Unstained cells and cells stained with directly conjugated antibodies 155 
were resuspended in 100 l PBS for analysis on the MACSQuant flow cytometer [in 156 
Boston (Miltenyi Biotec)] or the BD FACScalibur [in Senegal (BD Biosciences)].  157 
Erythrocytes incubated with all other antibodies were then incubated in anti-mouse IgG-158 
Alexa Fluor 488 (1:1,000, Life Technologies) for 30 min at room temperature.  Control 159 
samples with no prior antibody incubation were incubated in either anti-mouse IgG2a-PE 160 
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(1:10, Miltenyi Biotec) or anti-mouse IgG-Alexa Fluor 488.  Cells were washed twice 161 
and subjected to flow cytometric analyses.  The data were analyzed using FlowJo 4 v. 162 
10.0.7 for flow cytometry done in Boston or FlowJo v. 8.8.6 for flow cytometry done in 163 
Senegal. 164 
Quantitative cell surface proteomics. pLKO control, GPA knockdown, GPB 165 
knockdown and GPC knockdown cultured erythrocytes (cRBCs) were prepared as 166 
described earlier in the text. The following sets of cells were labeled by aminooxy-biotin 167 
as described previously (44, 45) – pLKO cRBCs: 10.2 x 106 cells (in duplicate); GPA 168 
KD: 16.2 x 10
6
 cells; GPB KD: 3.5 x 10
6
 cells; GPC KD: 11.2 x 10
6
 cells; peripheral 169 
RBCs: 10.0 x 10
6
 cells (in duplicate). 170 
Briefly, surface sialic acid residues were oxidized with sodium meta-periodate 171 
(Thermo) then biotinylated with aminooxy-biotin (Biotium). The reaction was quenched, 172 
and the biotinylated cells incubated in a 1% Triton X-100 lysis buffer. Biotinylated 173 
glycoproteins were enriched with high affinity streptavidin agarose beads (Pierce) and 174 
washed extensively. Captured protein was denatured with dithiotreitol (Sigma-Aldrich), 175 
alkylated with iodoacetamide (IAA, Sigma) and digested on-bead with trypsin (Promega) 176 
in 200 mM HEPES pH 8.5 for 3 hours. Tryptic peptides were collected and labeled using 177 
TMT reagents (Thermo Scientific). The reaction was quenched with hydroxylamine, and 178 
TMT-labeled samples combined in a 1:1:1:1:1:1:1 ratio. Labeled peptides were enriched 179 
and desalted and then 6% of the total sample was subjected to mass spectrometry. 180 
Mass spectrometry data was acquired using an Orbitrap Fusion coupled with an 181 
UltiMate 3000 Nano LC (Thermo). Peptides were separated on a 75 cm PepMap C18 182 
column (Thermo). Peptides were separated using a 180 min gradient of 3 to 33% 183 
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acetonitrile in 0.1% formic acid at a flow rate of 200 nL/min. Each analysis used a 184 
MultiNotch MS3-based TMT method (45, 46). The scan sequence began with an MS1 185 
spectrum (Orbitrap analysis, resolution 120,000, 400-1400 Th, AGC target 2 x 105, 186 
maximum injection time 50 ms). MS2 analysis consisted of CID (quadrupole ion trap 187 
analysis, AGC 15,000, NCE 35, maximum injection time 120 ms). The top ten precursors 188 
were selected for MS3 analysis, in which precursors were fragmented by HCD prior to 189 
Orbitrap analysis (NCE 55, max AGC 2 x 105, maximum injection time 150 ms, isolation 190 
specificity 0.5 Th, resolution 60,000).  191 
Sample collection for ex vivo invasion assays and erythrocyte receptor expression.  192 
Collection of clinical isolates and their experimental use were approved by the Ethics 193 
Committee of the Ministry of Health in Senegal and by the Institutional Review Board of 194 
the Harvard T.H. Chan School of Public Health. Sample collection was done in 195 
November 2013, towards the end of the transmission season in Senegal. After informed 196 
consent from patients presenting with uncomplicated malaria in Thies, Senegal, ~4 ml of 197 
whole blood was collected from each patient in Sodium Citrate Vacutainers and 198 
transported to Dakar, Senegal. Samples arrived in the laboratory within 6 hours of draw 199 
and after washes in incomplete RPMI and removal of the buffy coat, a fraction of 200 
parasitized cells was enzyme-treated with Vibrio cholerae neuraminidase (Sigma-201 
Aldrich), chymotrypsin (Worthington) and trypsin and placed in culture conditions until 202 
invasion assay set up. 203 
For measurement of erythrocyte receptor expression in healthy Senegalese, 2-3 ml of 204 
whole blood was collected from healthy donors from the Senegalese National Blood 205 
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Transfusion Center in Dakar, Senegal. Flow cytometry was performed on the day of 206 
blood collection. 207 
Parasite cultures.  P. falciparum cultures were maintained in human O
+
 erythrocytes. 208 
Parasites were grown at 2% hematocrit in complete RPMI medium (incomplete RPMI 209 
supplemented with 2.57 mM sodium bicarbonate (Sigma-Aldrich), 0.25% AlbuMAX II 210 
(Life Technologies) and 0.25% AB
+
 serum (for ex vivo cultures) or 0.5% AlbuMAX II 211 
for laboratory strains and the short-term culture-adapted strain.  Cultures were kept at 212 
37°C in a modulator incubator chamber, gassed with 1% O2, 5% CO2 and 94% N2. 213 
Enzyme treatments. Ring stage parasite cultures were washed three times in incomplete 214 
RPMI and treated with 1 mg/ml trypsin, 1 mg/ml chymotrypsin and 66.7 mU/ml of 215 
Vibrio cholerae neuraminidase for 1 h at 37C, with gentle mixing.  Enzyme-treated cells 216 
were then washed twice in incomplete RPMI and once in complete RPMI, then 217 
resuspended at 2% hematocrit (HCT) in complete RPMI and placed in culture.    218 
Invasion Assays.  Invasion assays were performed in half-area 96-well plates in 219 
duplicate or triplicate.  At the late trophozoite or schizont stage, the parasite culture was 220 
resuspended and adjusted to 0.5% HCT based on hemocytometer cell counts, for ex vivo 221 
invasion assays in Senegal, or based on volume, for invasion assays conducted in Boston. 222 
GPA-, GPB- and GPC-knockdown cultured erythrocytes (cultured red blood cells; 223 
cRBCs) and pLKO cRBCs were adjusted to 0.5% HCT based on hemocytometer cell 224 
counts.  Parasitized cells were added to cRBCs at an 80:20 ratio (see Fig. 4B).  For ex 225 
vivo invasion assays in Senegal, 10 l of the total sample volume of 40 l was used for 226 
smears to determine the starting parasitemia by light microscopy.  Boston-based invasion 227 
assays were performed with a total sample volume of 30 l.  Assays were harvested 30-228 
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40 hours post-set up by making smears or cytospin preparations, which were stained with 229 
May-Grünwald and Giemsa to determine final parasitemia by light microscopy.  500-230 
2000 erythrocytes were counted, depending on the experiment.  The invasion efficiency 231 
based on final parasitemia was determined for each strain after normalization to pLKO 232 
control cells.  233 
Statistical Analyses. Univariate analyses were performed using GraphPad Prism v. 5.0 234 
for Mac OS X. Significant differences between each knockdown group and control group 235 
were determined using a one-way ANOVA and Dunnett’s multiple comparison test. 236 
Data analysis for quantitative surface proteomics. Mass spectra were processed using 237 
a Sequest-based in-house software pipeline as previously described (47). Data were 238 
searched using the human Uniprot database (April 2014) concatenated with common 239 
contaminants, and filtered to a final protein-level false discovery rate of 1%. Proteins 240 
were quantified by summing TMT reporter ion counts across all peptide-spectral matches 241 
using in-house software as previously described (47), excluding peptide-spectral matches 242 
with poor quality MS3 spectra (a combined signal:noise ratio of less than 250 across all 243 
TMT reporter ions). For protein quantitation, reverse and contaminant proteins were 244 
removed.  245 
A subset of 78 membrane proteins were identified based on the presence of the 246 
following criteria extracted from the UniProt (48) database (type I/II/III/IV 247 
transmembrane domain, multipass transmembrane domain, GPI-anchored, lipid 248 
anchored) or predictions of transmembrane helices based on the TMHMM 2.0 program 249 
(49, 50). Each reporter ion channel was summed across all 78 proteins and normalized 250 
assuming equal protein loading across all samples. To compare the relative abundance of 251 
 12 
the membrane proteins between the pLKO cRBCs and KD cRBCs, proteins with a 252 
coefficient of variation > 0.25 in the pLKO technical replicates were excluded from 253 
further analysis. 254 
Fold change for each protein was calculated according to signal:noise (GYP 255 
KD)/average signal:noise (pLKO controls). P-values (Significance A) were calculated 256 
and adjusted with the Benjamini-Hochberg method using Perseus v. 1.5.1.6 (51). To 257 
compare the abundance of plasma membrane proteins between pLKO cRBCs and 258 
peripheral RBCs, for each protein the normalized signal for each reporter channel was 259 
renormalized to a total of 1 and the data were clustered using the k-means algorithm in 260 
Cluster v. 3.0 with a Euclidean distance metric (52) and subsequently displayed using 261 
TreeView v. 1.1.6r4 (53). 262 
 263 
 264 
Results 265 
 266 
Glycophorin B transcript levels vary widely amongst healthy individuals in a 267 
malaria-endemic region  268 
Erythrocyte receptors involved in P. falciparum invasion and their regulatory 269 
regions harbor polymorphisms, some of which are overrepresented in malaria-endemic 270 
regions and are suggested to have arisen as a consequence of the selective force of 271 
malaria on the human genome. To determine if we could identify additional 272 
polymorphisms that might affect P. falciparum infection, we performed computational 273 
analysis of transcriptional profiles generated from whole blood of children in Benin, 274 
published by Idaghdour et. al (36).  We first defined a subset of erythroid-specific genes 275 
from the transcriptome based on the HaemAtlas published by the Bloodomics 276 
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Consortium (38) and from known blood groups. Of 238 erythroid-specific/blood group 277 
transcripts from 61 healthy children included in the analysis, we identified four genes 278 
with wide expression range (95 quantile to 5 quantile ratio larger than 10, z score > 3): 279 
carbonic anhydrase 1 (CA1), hemoglobin zeta chain (HBZ), RAP1 GTPase activating 280 
protein (RAP1GAP) and unexpectedly, GYPB (Fig. 1A). Importantly, many transcripts 281 
with little variation served as internal controls (Fig. 1A). 282 
To determine if this GYPB transcript variation translated to receptor expression 283 
variation, we measured the levels of GPB, as well as GPA, GPC and other blood group 284 
receptors in healthy donors in the malaria endemic country of Senegal over two 285 
consecutive years (Fig.  1B). The variation in surface expression of GPB in GPB-positive 286 
individuals, estimated by the 95/5 quantile ratio, was ~1.5 fold above background, much 287 
smaller than the transcriptional variation found in the Beninese children. We also 288 
observed modest variation in surface expression of other receptors we measured, with a 289 
95/5 quantile ratio ranging from ~1.2 to 3 (Fig. 1B).  290 
 291 
Knockdown of GPA, GPB or GPC in ex vivo cultured erythrocytes  292 
To understand expression level modulation of GPB in P. falciparum invasion and 293 
to determine the importance of this receptor relative to the other major sialic acid-294 
dependent receptors, GPA and GPC, we knocked down expression of GPB in ex vivo 295 
cRBCs via shRNA-mediated gene silencing (37). In 6-7 independent experiments, we 296 
achieved approximately 53.5 ± 8.9% standard deviation (SD) knockdown (KD) of GPA 297 
(P ≤ 0.001), 72.3 ± 14.2% SD KD of GPB (P ≤ 0.001) and 82.9 ± 6.5% SD KD of GPC 298 
(P ≤ 0.001) (Fig. 2A and 2B), as determined by flow cytometry. We also measured the 299 
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expression level of all of the glycophorins (between three and seven times), and 300 
following KD of each receptor, found little change in the expression levels of the others 301 
by flow cytometry (Fig. 2B).  We further measured surface expression by flow cytometry 302 
of other known Plasmodium receptors (BSG, band 3, CR1 and DARC) (Fig. S1). We 303 
observed a four-fold increase in band 3 levels following GPA KD as previously reported 304 
(54) a two-fold increase in BSG levels on GPA KD cells, and a ~25% decrease in BSG 305 
levels on GPB KD cells.  Further, we found no association between GPB and BSG levels 306 
by flow cytometry in Senegalese individuals (Fig. 1B). In addition, KD and pLKO 307 
control cRBCs had normal erythrocyte morphology (Fig. 2C). 308 
 309 
Global proteomic profiling to determine the level and specificity of GPA, GPB and 310 
GPC receptor knockdowns 311 
 To establish the similarity between cRBCs and physiologically derived red blood 312 
cells (pRBCs), we measured expression of 78 cell surface receptors by plasma membrane 313 
profiling (PMP) on cRBCs and pRBCs (Table S1).  Firstly, this analysis demonstrated the 314 
reticulocyte-like nature of the cRBCs by showing that several proteins that decrease in 315 
abundance during reticulocyte maturation, including CD71 (TFRC) (55, 56), CD36 (57, 316 
58), ITGA4 (58), and SLC3A2 (59), were decreased in pRBCs relative to pLKO cRBCs 317 
(Cluster 1; Fig. 3A).  The level of expression of proteins in Cluster 2 remained 318 
unchanged between pRBCs and pLKO cRBCs, while Cluster 3 proteins were enriched on 319 
pRBCs, and include GPA, and GPC. (By this method we are unable to distinguish 320 
between GPA and GPB peptides, thus due to the ~four-fold greater abundance of GPA 321 
receptors, we assume that the signal emanates from a ratio of 4:1 for GPA:GPB.) 322 
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We have calculated the numbers of molecules per unit surface area of known P. 323 
falciparum host receptors (46, 60–66) (Table 1), using published values of the surface 324 
area of reticulocytes (142.4 ± 2.0 µm
2
) and pRBCs (133.6 ± 3.0 µm
2
) (46). We find that 325 
the surface density of receptors between pLKO cells and pRBCs for all known receptors, 326 
are within three-fold of each other, except for CR1 which is ~five-fold lower on pLKO 327 
cRBCs. GPA/GPB and GPC are found at lower levels on pLKO cells, while BSG is the 328 
only major receptor that is found at a higher level. The lower density of GPA/ GPB and 329 
GPC on pLKO cells suggests that further limitation of receptor densities by knockdown 330 
will elicit receptor densities significantly lower than those observed on pRBCs (Table 1). 331 
To ensure that the specificity of invasion phenotypes would result specifically 332 
from the receptors that were depleted, we made a comparison of pLKO and KD cRBCs. 333 
As expected, GPA and GPC were reduced in the GPA and GPC KD cRBCs respectively 334 
(Fig. 3B, 3D). As mentioned earlier, GPA and GPB peptides are indistinguishable; 335 
therefore GPB depletion in the GPB KD cells was not observable by this analysis. Of all 336 
the known receptors considered, only BSG levels were reduced in any of the KDs (albeit 337 
at borderline significance, P = 0.047) (Table S1, Fig. 3C), in GPB KD cells. Calculated 338 
surface densities of BSG on GPB KD cells are comparable to those found on pRBCs 339 
(Table 1), suggesting that BSG is not limited to levels that would contribute to an 340 
invasion phenotype. This analysis also revealed other proteins that have significantly 341 
altered levels in the pLKO cRBCs relative to KD cRBCs (Fig. 3B-D, Table S2). To date, 342 
no role in invasion has been described for these proteins.  343 
Interestingly, band 3 (SLC4A1) levels were not significantly elevated by 344 
proteomic analysis on GPA KD cells (Fig. 3B), in contrast to the significant increase in 345 
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band 3 levels determined by flow cytometry  (Fig. S1) (67, 68). One potential explanation 346 
for the discrepancy is that knockdown of GPA improves accessibility of the band 3 347 
antibody to its epitope during flow cytometry measurements.  348 
 349 
A scaled-down assay for measuring erythrocyte invasion efficiency 350 
To enable us assess invasion profiles of as many P. falciparum strains as possible, 351 
we developed a scaled-down invasion assay that makes use of small numbers of cells of 352 
interest (Fig. 4A).  In our assay design, a P. falciparum culture treated with 353 
neuraminidase (N), trypsin (T) and chymotrypsin (C), constituting donor cells, is added 354 
to cells of interest (acceptor cells) in an 80:20 ratio and parasitemia is determined after a 355 
single round of invasion.  We used the 80:20 ratio of donor to acceptor cells over other 356 
ratios because the 80:20 ratio allowed us to use a limited number of cultured 357 
erythrocytes, yet gave us a reasonable, measurable final parasitemia of 3% when 358 
assessing invasion of 3D7 into pLKO control cells with a starting parasitemia of ~2% 359 
(Fig. 4B).  The success of this scaled-down assay depends on effective NTC treatment to 360 
prevent re-invasion into donor cells, careful counting of acceptor cells (achieved with a 361 
hemocytometer) and a reasonable starting parasitemia in the donor culture (ideally 2.5%), 362 
since only 20% of the cells in each sample have intact receptors for invasion.  363 
 364 
Glycophorin B is a major receptor used by P. falciparum laboratory strains  365 
To assess the relative importance of GPB in invasion, we tested invasion of KD 366 
cRBCs by a panel of wild type P. falciparum laboratory-adapted strains and invasion 367 
ligand deletion strains.  Using our scaled-down invasion assay, we observed decreased 368 
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invasion of the sialic acid-dependent strain, Dd2, into GPB KD cRBCs (56.4 ± 24.2% 369 
SD) as well as GPA KD cRBCs (72.9 ± 18.3%, SD) as previously reported (37), but no 370 
change in invasion of GPC KD cells (91.8 ± 8.2% SD) relative to pLKO control cells 371 
(Table 2).  372 
It has been shown that strain 3D7 uses the sialic acid-dependent EBA-175/GPA 373 
invasion pathway to some extent (23). We did not observe a decrease in invasion of 3D7 374 
into GPA KD cRBCs consistent with a previous report (37), however, the parent 3D7 375 
strain and the derived invasion ligand deletion lines, 3D7∆EBA-175 and 3D7∆Rh2b, had 376 
decreased invasion into GPB KD cRBCs (Table 2). This decrease reached statistical 377 
significance for 3D7  (66.6 ± 23.3% SD and 3D7∆Rh2b (60.5% ± 26.6% SD), indicating 378 
that in 3D7, the GPB receptor is more important than the GPA receptor.  None of the 3D7 379 
strains showed decreased invasion into GPC KD cRBCs (Table 2), suggesting a lesser 380 
role in invasion for this receptor.  381 
Like 3D7, the sialic acid-independent strains 7G8 and HB3 showed decreased 382 
invasion of GPB KD cells, though this decrease was not statistically significant (Table 2).  383 
We did not observe decreased invasion of 7G8 or HB3 into GPA or GPC KD cRBCs, 384 
relative to pLKO cRBCs. Altogether, our data suggest that GPB is important for invasion 385 
by the tested sialic acid-dependent and sialic acid-independent laboratory strains of P. 386 
falciparum. 387 
 388 
Many P. falciparum field isolates use glycophorin B for invasion.  389 
To determine if GPB is important in invasion by field isolates, we assessed 390 
invasion of a culture-adapted Senegalese isolate and fresh clinical isolates from Senegal 391 
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into KD cRBCs (Tables 2 and 3). Sen51, a short-term culture-adapted strain, which was 392 
sensitive to neuraminidase treatment [defined as invasion efficiency of less than 60% into 393 
neuraminidase(Nm)-treated pRBCs that are devoid of sialic acid (Table S3)], showed 394 
decreased invasion into GPB KD cRBCs (58.8 ± 16.8% SD) compared to GPA KD 395 
cRBCs (109.7 ± 28.3% SD)  and GPC KD cRBCs (113.0 ± 3.6% SD) (Table 2).   396 
For invasion of fresh clinical isolates, five out of eight strains had less than 60% 397 
invasion into GPB KD cRBCs as well as GPA KD cRBCs, while none of the five had 398 
less than 60% invasion into GPC KD cRBCs relative to pLKO cRBCs (Table 3). Of these 399 
five isolates, three were sensitive to Nm-treated pRBCs (Th303, Th305 and Th306), 400 
while two were resistant (Th304 and Th312). Two other isolates, which had decreased 401 
invasion only into GPC KD cRBCs were sensitive to Nm-treated pRBCs (Th266 and 402 
Th268), bringing the proportion of Nm-sensitive strains to 75% (six out of eight strains). 403 
Invasion into GPB KD cells ranged from 36.7 ± 5.8% SD to 118.0 ± 66.4% SD, while the 404 
range for GPA KD cells was 28.5 ± 3.5% SD to 110.4 ± 60.7% SD and for GPC KD 405 
cells, 52.5 ± 16.4% SD to 93.5 ± 42.2% SD (Table 3). Overall, our results indicate that 406 
for field isolates, GPB is of comparable importance in invasion as GPA, and more 407 
utilized than GPC for most strains tested, though there is more heterogeneity in receptor 408 
usage for field isolates than lab lines. Furthermore, there is not a simple relationship 409 
between sialic acid-dependence and the invasion phenotype into KD cRBCs. 410 
 411 
Discussion  412 
In this study we have used erythrocyte reverse genetics in an isogenic background 413 
to specifically and comparatively assess the use of three major sialylated erythrocyte 414 
receptors – GPA, GPB and GPC – in invasion of erythrocytes by P. falciparum 415 
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laboratory-adapted and field strains. We used genetically altered cRBCs to evaluate the 416 
contribution of specific invasion ligands in isogenic cells in ex vivo parasite invasion 417 
assays. This contrasts with previous studies, which depend on enzyme-treated cells and 418 
non-isogenic naturally occurring mutant erythrocytes to reveal invasion pathways (54). 419 
The cRBCs used in this study express the full complement of P. falciparum receptors and 420 
are of a relatively homogeneous age, though their reticulocyte-like nature results in some 421 
differences in surface receptor abundance, relative to pRBCs. Nevertheless, we achieved 422 
limiting numbers of receptors on KD cells, enabling us to determine the relative 423 
importance of specific receptors. In comparing invasion into GPA, GPB, and GPC KD 424 
cells, we observed a dependence on GPB by both sialic acid-dependent and sialic acid-425 
independent laboratory strains; this reliance on GPB was greater than GPA, which is used 426 
by many laboratory strains regardless of sialic acid-dependence (21, 23).  Our data also 427 
suggest that the GPC receptor is less important for invasion in most strains tested.   428 
Bioinformatic analysis of transcriptional profiles of Beninese children revealed a 429 
wide variation in GYPB transcript levels and one factor that might contribute to this is 430 
GYPB genetic polymorphisms in Africans. A high prevalence of the GPB null genotype 431 
exists in malaria-endemic regions and amongst individuals of African descent – ranging 432 
from 2-8% in West Africa to as high as 59% amongst the Efe pygmies in the Democratic 433 
Republic of Congo (69, 70) – suggesting that malaria pressure selected for this 434 
polymorphism. The Dantu variant of GPB, representing a hybrid GPA-GPB molecule 435 
with a GPB N-terminal region and a GPA C-terminal region, has been shown to confer 436 
protection against invasion and growth of P. falciparum in vitro (71). A recent study has 437 
found evidence for a strong protective effect of the Dantu NE genotype against cerebral 438 
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malaria and severe malaria anemia in East Africa (70).  The Dantu NE genotype, which 439 
results from an intricate structural modification of the GYPE-GYPB-GYPA locus 440 
including deletion of the 3’ end of GYPB, was found to have arisen recently in Kenya. In 441 
addition to the Dantu variant, the authors identified multiple examples of deletions and 442 
duplications at the GYPE-GYPB-GYPA locus. In our study, we did not observe variation 443 
in GPB surface expression in healthy Senegalese to the same extent as that seen for 444 
transcription in Beninese individuals, suggesting that transcriptional differences in GYPB 445 
do not directly reflect surface receptor expression. Alternatively, it is possible that there 446 
are country-specific differences in GYPB polymorphisms, such that Beninese, but not 447 
Senegalese individuals exhibit GYPB transcriptional variation with concomitant variation 448 
in surface expression levels. Further investigation is required to understand the origin and 449 
significance of GYPB transcriptional variation.  450 
The observation from this work that GPB is an important receptor for P. 451 
falciparum invasion is at odds with work showing that some laboratory-adapted strains 452 
(72, 73)  and field isolates from Kenya (74), Columbia and Peru (75) have either an ebl-1 453 
gene deletion, a thymidine insertion or a premature stop codon that results in a truncated 454 
EBL-1 product.  Prior to these findings, some of the studies that had reported use of the 455 
EBL-1/GPB invasion pathway had used P. falciparum strains that have a mutated or 456 
deleted ebl-1 gene, for example 7G8, 3D7 or HB3 (33, 35), suggesting that perhaps there 457 
is an additional parasite ligand that binds to GPB.  In this study, we observe usage of 458 
GPB by laboratory strains that are reported to lack a functional EBL-1 ligand: 7G8, 3D7 459 
(73) and HB3 (72), further suggesting that there is an additional parasite ligand for GPB. 460 
Such a ligand may have features in common with the other P. falciparum invasion 461 
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ligands that bind glycophorins (EBA-175, EBL-1 and EBA-140), such as a DBL-like 462 
domain. 463 
Importantly, our work demonstrates that many field strains use GPB for invasion.  464 
Given this dependence on GPB in a region with GPB null prevalence, it would be 465 
relevant to genotype field isolates to determine if there are any mutations in ebl-1, as has 466 
been noted in some field isolates in Kenya (74), Columbia and Peru (75), and in the 467 
absence of inactivating mutations, to determine if invasion-inhibitory EBL-1 antibodies 468 
exist in the Senegalese population. Identifying an alternate invasion ligand that binds to 469 
GPB would warrant assessing usage by field isolates and determining the ability of 470 
naturally acquired antibodies against this ligand to block invasion, which may lead to 471 
consideration of this ligand for inclusion in an invasion-blocking subunit vaccine. 472 
Eight of the nine field strains in this study showed decreased invasion into either 473 
GPA, GPB, and/or GPC KD cells, emphasizing the sialic acid-dependent nature of many 474 
Senegalese strains. We also found that several field isolates had decreased invasion into 475 
Nm-treated pRBCs, consistent with previous field studies reporting decreased invasion of 476 
Nm-treated pRBCs  (15, 18, 26, 76). However, we did not find a simple concordance 477 
between decreased invasion into GPA, GPB and GPC KD cRBCs and sialic acid-478 
dependence (as determined by invasion into Nm-treated pRBCs) (Table S3), 479 
underscoring the importance of separately assessing specific receptors. In this study, we 480 
have investigated the use of three major sialylated receptors, and in so doing, highlighted 481 
the lesser role of GPC compared with GPA or GPB. The minor role of the EBA-140/GPC 482 
invasion pathway, especially in laboratory strains, is in concordance with other studies 483 
(21, 23).  Knockout of the EBA-140 invasion ligand is facile in all laboratory strains (9), 484 
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and in contrast to knockouts of EBA-175, does not lead to a change in the use of ligand-485 
receptor interactions (23).  Jiang et al., show that chymotrypsin treatment of GPA-null 486 
cells (En(a-)) causes an almost complete block in invasion of ten P. falciparum laboratory 487 
strains (21). Both the EBA-175/GPA and the EBA-140/GPC invasion pathways are 488 
chymotrypsin-resistant, indicating minimal use of the EBA-140/GPC invasion pathway in 489 
the absence of GPA (21).  In addition, the limited requirement of GPC for erythrocyte 490 
invasion can be viewed in light of the interaction between the subtelomeric variant open 491 
reading frame protein (STEVOR) and GPC (77) for the rosetting of parasite-infected 492 
erythrocytes, suggesting an additional role for this erythrocyte receptor. 493 
Recent studies have provided more evidence to demonstrate the importance of 494 
deformability in the invasion process (78, 79). We did not measure deformability of KD 495 
cRBCs, however, it is unlikely that changes in deformability of cRBCs as a result of 496 
receptor KDs account for the invasion phenotypes of P. falciparum strains into KD 497 
cRBCs. This is because GPA null cells and GPB null cells have similar deformability and 498 
membrane mechanical stability as WT pRBCs  (80), whereas GPC null cells reportedly 499 
have decreased membrane stability and deformability (80). But the majority of P. 500 
falciparum strains in this study had normal invasion into GPC KD cRBCs. 501 
 Altogether, the genetic evidence presented in this study reveals that the GPB 502 
invasion pathway is important for invasion of strains tested.  Our study provides the 503 
impetus for a more detailed investigation into the use of GPB by alternative invasion 504 
ligands, and the use of EBL-1 in invasion by field isolates, both of which could 505 
contribute to the dominance of GPB as a receptor in the hierarchy of the RBL and EBL 506 
invasion ligands. 507 
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Figure Legends 801 
 802 
Figure 1. Glycophorin B transcriptional variation and erythrocyte receptor 803 
expression amongst individuals in malaria-endemic regions. A. Graph highlighting 804 
transcripts, including GYPB, whose abundance varied widely amongst erythroid-specific 805 
transcripts from 61 healthy individuals in Benin. Bioinformatic analysis was based on the 806 
whole blood transcriptomics study of malaria-infected and healthy children in Benin (36). 807 
 36 
B. Expression of GPB and other erythrocyte receptors from blood of healthy Senegalese 808 
donors in 2011 (left graph) and 2012 (right graph). The graphs show the 95/5 quantile 809 
ratio normalized to the quantile ratio for a control secondary antibody. The quantile ratio 810 
was based on mean fluorescence intensity values determined by flow cytometry. In 2011, 811 
measurements were made on RBCs from 29 donors (GPB) or 32 donors (CD55, CR1) or 812 
41 donors (RhD), and in 2012, on 11 donors (GPB) or 29 donors (all other receptors). In 813 
2011, one GPB null individual and three RhD null individuals were observed but were 814 
excluded from measurement of the 95/5 quantile ratio. In 2012, three different probes 815 
were used to measure expression of GPA and GPC (see Materials and Methods). 816 
 817 
Figure 2. Knockdown of glycophorin A, B and C in cultured erythrocytes.  A. 818 
Expression of glycophorin A (GPA), glycophorin B (GPB) and glycophorin C (GPC) on 819 
the cell surface of GPA knockdown (KD) (green), GPB KD (blue) and GPC KD (pink) 820 
cultured erythrocytes (cRBCs) as determined by flow cytometry.  Representative flow 821 
cytometry plots are shown. Grey traces: receptor expression on pLKO cRBCs; dashed 822 
traces: pLKO cells stained with a control antibody. B. Mean expression ± standard error 823 
from three to seven independent experiments, normalized to expression on pLKO cells. 824 
For measurement of GPB expression, cRBCs were treated with trypsin to remove GPA 825 
and cells stained with a GPA/B antibody. Statistical significance was determined using a 826 
one-way analysis of variance (ANOVA) with a Dunnett’s multiple comparison test. 827 
Significant differences are indicated by ***P ≤ 0.001. C. May-Grünwald, Giemsa-stained 828 
cytospins showing normal morphology of KD and pLKO control cRBCs. cRBCs were 829 
 37 
passed through a 5 µm filter to remove nucleated cells prior to flow cytometry and 830 
cytospin preparation. 831 
 832 
Figure 3. Quantitative cell surface proteomics of peripheral erythrocytes and 833 
cultured erythrocytes. A. Quantitative cell surface proteomic comparison between 834 
pLKO cRBCs and peripheral RBCs (pRBCs). K-means clustering analysis of the 78 835 
surface membrane proteins identified three clusters: cluster 1 – proteins that decrease 836 
between pLKO cRBCs and pRBCs; cluster 2 – proteins that remain at the same level 837 
between pLKO cRBCs and pRBC; and cluster 3 – proteins that increase between pLKO 838 
cRBCs and pRBCs. Scale bar represents normalized relative abundance of each protein. 839 
Note that the peptides detected by this technique did not allow a distinction to be made 840 
between GPA and GPB. B – D. Comparison of the relative abundance of membrane 841 
proteins between the pLKO control cRBCs and either the GPA KD cRBCs (B), GPB KD 842 
cRBCs (C) or GPC KD cRBCs (D). Fold change was calculated as: signal:noise (GP 843 
KD)/average signal:noise (pLKO control). Y-axes show the average signal:noise (S:N) 844 
across all samples. P-values were estimated using Benjamini-Hochberg corrected 845 
Significance A, calculated in Perseus v 1.5.1.6. 846 
 847 
Figure 4. Schematic of invasion assay design. A. A ring stage parasite culture is treated 848 
with neuraminidase (N), trypsin (T) and chymotrypsin (C), returned to culture conditions 849 
and allowed to mature to late trophozoite (troph) or schizont stage. The NTC-treated 850 
culture (donor cells) is mixed in an 80:20 ratio with either knockdown (KD) or control 851 
pLKO cRBCs (acceptor cells). Initial parasitemia and/or final parasitemia after one round 852 
 38 
of invasion are determined either by microscopy from counts of 500-2000 erythrocytes or 853 
by flow cytometry of SYBR green I-stained cells. Invasion assays are set up at 0.5% 854 
hematocrit. All acceptor cells are counted by hemocytometer prior to assay setup. B. 855 
Invasion of NTC-treated P. falciparum 3D7 into pLKO control cRBCs with varying ratio 856 
of enzyme-treated donor cells to pLKO acceptor cells. 100:0 ratio indicates NTC-treated 857 
3D7 donor cells and no pLKO cRBCs. Initial parasitemia was ~2%. Final parasitemia 858 
was determined by flow cytometry of SYBR green I-stained cells. The assay was 859 
performed once in duplicate. Bars represent the mean ± the range. The 80:20 ratio was 860 
selected for subsequent invasion assays. E: Expected parasitemia based on invasion into 861 
50:50 mixture. O: Observed parasitemia. 862 
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Table 1. Comparison of copies per unit surface area of known P. falciparum host 888 
receptors on peripheral erythrocytes and cultured erythrocytes. 889 
 890 
 891 
The reported number of copies of known P. falciparum host receptors on peripheral 892 
erythocytes (pRBCs) were used to estimate the number of copies of host receptors on 893 
pLKO cRBCs based on the normalized signal:noise ratios from quantitative surface 894 
proteomics and the following reported surface areas for mature RBCs: 133.6 ± 3.0 µm
2
 895 
and for reticulocytes: 142.4 ± 2.0 µm
2
 (46), which we assume to be representative of 896 
pLKO cRBCs. Since GPA and GPB peptides are indistinguishable by surface proteomics, 897 
estimation was based on the reported relative abundance of GPA and GPB on pRBCs. 898 
The densities of host receptors per unit surface area for GPA, GPB, and GPC are within 899 
three-fold lower on pLKO cRBCs compared to pRBCs.  900 
 901 
 902 
 903 
 904 
 905 
Copies/µm
2
 
Protein pRBC pLKO GPA KD GPB KD GPC KD 
GPA
(62-64, 66)
 7.49 x 10
3
 4.42 x 10
3
 1.25 x 10
3
 1.62 x 10
3
 2.38 x 10
3
 
GPB
(62-64, 66)
 1.87 x 10
3
 1.11 x 10
3
 3.11 x 10
2
 4.05 x 10
2
 5.95 x 10
2
 
GPC
(62-64, 65)
 7.49 x 10
2
 2.57 x 10
2
 1.52 x 10
2
 1.62 x 10
2
 9.51 x 10
1
 
BSG
(61, 64)
 2.25 x 10
1
 6.26 x 10
1
 8.72 x 10
1
 2.21 x 10
1
 6.52 x 10
1
 
CR1
(64)
 
1.50 - 8.98 
x 10
0
 
0.31 - 1.84 x 
10
0
 
0.41 - 2.43 x 
10
0
 
0.38 - 2.31 
x 10
0
 
0.52 - 3.13 x 
10
0
 
Band 3
(61)
 7.49 x 10
3
 3.53 x 10
3
 4.68 x 10
3
 1.97 x 10
3
 3.26 x 10
3
 
Kx
(61)
 7.49 x 10
0
 8.81 x 10
0
 1.05 x 10
1
 7.04 x 10
0
 8.36 x 10
0
 
CD55
(61)
 1.50 x 10
2
 1.59 x 10
2
 1.49 x 10
2
 9.47 x 10
1
 1.42 x 10
2
 
CD44
(60, 61)
 2.62 x 10
1
 4.47 x 10
1
 6.66 x 10
1
 3.05 x 10
1
 3.64 x 10
1
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Table 2. Invasion efficiency of P. falciparum laboratory-adapted strains and a 906 
Senegalese culture-adapted isolate into knockdown cultured erythrocytes. 907 
  % Invasion Efficiency
a
 
Strain GPA KD GPB KD GPC KD 
Dd2 72.9  ±  18.3* 56.4  ±  24.2** 91.8  ±  8.2 
3D7 90.2  ±  11.4 66.6  ±  23.3*** 89.6  ±  9.8 
3D7ΔEBA175 100.4  ±  31.8 53.4 ±  30.0 94.1  ±  16.5 
3D7ΔRh2b 101.2  ±  14.8 60.5  ±  26.6* 100.2  ±  4.8 
7G8 85.0  ±  31.5 56.1  ±  26.8 98.3  ±  21.9 
HB3 101.3  ±  43.7 53.6  ±  18.1 93.0  ±  15.5 
Sen51                    109.7  ±  28.3             58.8  ±  16.8*           113.0  ±  3.6 ____ 908 
 909 
a
Invasion efficiency into KD cells relative to pLKO control cells; based on final 910 
parasitemia. Parasitemia was determined by microscopy from counts of 500-2000 911 
erythrocytes, depending on the experiment. Invasion assays were performed in triplicate, 912 
four to six times for 3D7, Dd2, 7G8, and HB3 and three times for 3D7ΔEBA-175, 913 
3D7ΔRh2b, and Sen51. Shown are the mean and standard deviation. Statistical 914 
significance was determined using a one-way ANOVA with a Dunnett’s multiple 915 
comparison test. Significant differences are indicated by *P < 0.05, **P ≤ 0.01 and ***P 916 
≤ 0.001. 917 
 918 
 919 
 920 
 921 
 922 
 923 
 924 
 925 
 926 
 927 
 928 
 929 
 930 
 931 
 932 
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Table 3. Invasion efficiency of P. falciparum ex vivo field isolates into knockdown 933 
cultured erythrocytes. 934 
 
% Invasion Efficiency
a
 
Strain GPA KD GPB KD GPC KD 
Th266 88.7 ± 12.1 66.2 ± 14.2 52.5 ± 16.4 
Th268 100.9 ± 28.1 79.1 ± 17.8 54.8 ± 9.4 
Th275 110.4 ± 60.7 118.0 ± 66.4 70.9 ± 10.0 
Th303 39.0 ± 4.1 55.6 ± 4.6 69.1 ± 2.5 
Th304 40.7 ± 1.6 56.0 ± 4.7 92.3 ± 24.9 
Th305 30.6 ± 0 36.7 ± 5.8 86.7 ± 10.1 
Th306 44.9 ± 0.1 47.6 ± 16.5 93.5 ± 42.2 
Th312 28.5 ± 3.5 51.7 ± 10.1 91.8 ± 2.0 
 935 
a
Invasion efficiency into KD cells relative to pLKO control cells; based on final 936 
parasitemia. Parasitemia was determined by microscopy from counts of 800-1000 937 
erythrocytes. Invasion assays were performed once, in triplicate (Th266, Th268, Th275) 938 
or duplicate (Th303, Th304, Th305, Th306, Th312). Errors indicate the standard 939 
deviation (Th266, Th268, Th275) or the range (Th303, Th304, Th305, Th306, Th312).  940 
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FIGURE S1. Characterization of glycophorin A-, B- and C-depleted cultured erythrocytes. A. 
Expression of P. falciparum invasion receptors (CR1 and BSG), band 3 and P. vivax receptor DARC on 
the surface of GPA KD, GPB KD and GPC KD cRBCs as determined by flow cytometry. Representative 
plots are shown. B. Mean expression ± standard deviation of P. falciparum invasion receptors (CR1 and 
BSG), DARC and band 3 receptors on the surface of GPA KD, GPB KD and GPC KD cRBCs as 
determined by flow cytometry from two to four experiments. cRBCs were passed through a 5 µm filter to 
remove nucleated cells prior to flow cytometry. 
 
 
 
TABLE S2. Description of proteins with significant fold change in abundance. 
 
cRBCs Protein Change P-value Description Function/ Role 
GPA KD PARK7 Decreased 0.0141 Protein DJ-1 
Positive regulator of 
androgen receptor-
dependent transcription. 
GPB KD BCAM Decreased 0.0312 
Basal Cell Adhesion 
Molecule, Lutheran 
Blood Group 
Member of the 
immunoglobulin 
superfamily. Receptor for 
the laminin extracellular 
matrix protein. 
GPB KD RHAG Decreased 0.0418 Ammonium transporter Rh type A 
Transport of ammonium 
and carbon dioxide across 
the erythrocyte membrane. 
GPB KD BSG Decreased 0.0474 Basigin, Ok Blood Group 
Essential role in P. 
falciparum invasion of 
erythrocytes. 
GPB KD SLC7A5 Increased 0.0381 
Large neutral amino 
acids transporter small 
subunit 1 
Transport of large neutral 
amino acids. 
GPB KD ATP12A Increased 0.0336 
Isoform 2 of Potassium-
transporting ATPase 
alpha chain 2 
ATPase, H+/K+ 
transporter. 
GPC KD SLC30A1 Increased 0.0464 Zinc transporter 1 
Transport of sugars, bile 
salts and organic acids, 
metal ions and amine 
compounds. 
GPC KD CD46 Increased 1.8441x107 
Complement Membrane 
Cofactor Protein 
Complement regulatory 
protein. 
	
	
	
	
	
	
	
	
	
	
TABLE S3. Table of neuraminidase sensitivity of P. falciparum strains. 
Strain IE into Nm pRBCsa Resistant/Sensitiveb Refs 
Dd2 N/A S (1) 
3D7 N/A R (2) 
3D7ΔEBA175 N/A R (2) 
3D7ΔRh2b N/A R (3) 
7G8 N/A R (4) 
HB3 N/A R (1) 
Sen51 50.8 ± 8.8 S This Study 
Th266 17.3 ± 7.5 S This Study 
Th268 51.1 ± 6.3 S This Study 
Th303 45.3 ± 11.4 S This Study 
Th304 105.6 ± 4.6 R This Study 
Th305 48.9 ± 7.6 S This Study 
Th306 14.1 ± 3.1 S This Study 
Th312 61.4 ± 22 R This Study 
aInvasion efficiency into neuraminidase-treated (Nm) pRBCs relative to untreated pRBCs; based 
on final parasitemia. Parasitemia was determined by SYBR green flow cytometry. Mean ± 
standard deviation (Sen51, Th266, Th268) or range (Th303, Th304, Th305, Th306, Th312) for 
one biological replicate. 
bSensitivity to neuraminidase treatment for field isolates in this study was based on a cutoff of 
60%. 
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